SCHEMBL2161963

SCHEMBL2161963

CC(C)(C)[Si](C)(C)OC(CCCCCCc1ccccc1)c1nnn(-c2cccs2)n1

nearest known ligand 0.49

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.31
DAGLA Q9Y4D2 1/20 0.31
CES1 P23141 1/20 0.31
LTB4R Q15722 1/20 0.31
F2 P00734 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2161841 0.87 FAAH (0.33) FAAHCES1
SCHEMBL2163247 0.82 SIRT1 (0.32) FAAHCES1
SCHEMBL2162815 0.82 FAAH (0.48) FAAHCES1POLB
SCHEMBL2162014 0.80 LTB4R (0.38) FAAHCES1LTB4R
SCHEMBL2161905 0.75 DAGLA (0.42) FAAHDAGLACES1
SCHEMBL2161859 0.74 FAAH (0.36) FAAHDAGLACES1LTB4R
SCHEMBL2162828 0.72 CES1 (0.41) FAAHCES1
SCHEMBL2161823 0.72 CES1 (0.41) FAAHCES1LTB4R
SCHEMBL2162285 0.71 CES1 (0.42) FAAHCES1
SCHEMBL12398417 0.69 FAAH (0.37) FAAHCES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987312-B2 Alpha-keto heterocycles as FAAH inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2015-03-24 US disclosed
US-8987312-B2 Alpha-keto heterocycles as FAAH inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2015-03-24 US disclosed
US-20110183947-A1 ALPHA-KETO HETEROCYCLES AS FAAH INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2011-07-28 US disclosed
US-20110183947-A1 ALPHA-KETO HETEROCYCLES AS FAAH INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183947-A1 ALPHA-KETO HETEROCYCLES AS FAAH INHIBITORS FAAH, FAAH2, FADS1 FAAH 1/4885DAGLA 289/4885CES1 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.